FLASH NEWS LIVE

ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion

ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion

ImmunityBio, Inc. remains a Buy, with Anktiva’s regulatory and global expansion driving the investment thesis. Learn more about IBRX stock here.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp